FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
0:00
3:00
Listen to a soundcast of the August 31, 2021 FDA approval of Brukinsa (zanubrutinib) for adult patients with Waldenström’s macroglobulinemia
Otros episodios de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
No te pierdas ningún episodio de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)”. Síguelo en la aplicación gratuita de GetPodcast.